Feed / ABBV

AbbVie Inc.

ABBV

Healthcare · 265.73 +0.4% today

Partial group confirmationMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

AbbVie Inc.'s move is being confirmed by its market group.

ABBV accounts for 0.1% of the group's measured movement across 7.1 effective names. raw member direction is mixed; 0 of 11 SPY-adjusted paths align to the mixed. Capital-flow agreement is 28%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

SPY-adjusted 5m paths
Role in the moveFlat / inactive path#11 of 11 by movement share
Group movement share0.1%Absolute path energy—not portfolio weight
Relative path-0.01%flat
Effective breadth7.1 / 11broad
Relative alignment0/11mixed path · 0 counter-moving
Capital-flow agreement28%not yet clean
SEQUENCE READ

No material onset for ABBV could be timestamped inside the aligned 5-minute window.

EVIDENCE COVERAGE

6 of 11 members in Biopharmaceuticals and Care are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 8 of 11 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as INVA begins moving with the group.

Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.

Watch this read

Who this business touches

The relationships behind ABBV

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

GMABGenmab A/SpartnerFeb 20, 2026

Epkinly • In May 2025, Genmab A/S (Genmab) announced positive topline results from the Phase 3 trial evaluating Epkinly plus rituximab and lenalidomide versus rituximab and lenalidomide alone in adult patients with relapsed or refractory (R/R) follicular lymp…

Depended on by

RGNX10.9% of RGNXcustomerMay 14, 2026

As of December 31, 2025 and 2024, the Company had recorded $ 10.9 million and $ 11.3 million, respectively, due from AbbVie for net reimbursement of costs incurred for activities performed under AbbVie Collaboration Agreement, which was included in other curr…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 27 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ABBV is currently a Early Follower in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.